From an early stage in his career, Miquel Vila-Perelló saw himself as a research academic. It was an ambition he duly fulfilled. Later, seeing the greater potential to bring benefit to human health by forming his own company, he co-founded SpliceBio, a Spain-based startup focusing on gene therapies for rare diseases.
Stargardt’s disease, a genetic eye disorder that causes retinal degeneration and vision loss, is the most prevalent of the rare diseases of the retina
